<SEC-DOCUMENT>0001062822-20-000045.txt : 20200730
<SEC-HEADER>0001062822-20-000045.hdr.sgml : 20200730
<ACCEPTANCE-DATETIME>20200730071814
ACCESSION NUMBER:		0001062822-20-000045
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20200729
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200730
DATE AS OF CHANGE:		20200730

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEXICON PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001062822
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				760474169
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30111
		FILM NUMBER:		201059179

	BUSINESS ADDRESS:	
		STREET 1:		8800 TECHNOLOGY FOREST PLACE
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381
		BUSINESS PHONE:		2818633000

	MAIL ADDRESS:	
		STREET 1:		8800 TECHNOLOGY FOREST PLACE
		CITY:			THE WOODLANDS
		STATE:			TX
		ZIP:			77381

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON PHARMACEUTICALS, INC./DE
		DATE OF NAME CHANGE:	20070426

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXICON GENETICS INC/TX
		DATE OF NAME CHANGE:	20000126
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lxrx-20200729.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:0f0ad0d9-de60-4423-9f15-cf8fc17a97ed,g:f4dc18c7-48ee-4acb-af6f-6184735fdbf4,d:23ecade57804410bb798455d50d75cec--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lxrx-20200729</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY180L2ZyYWc6ZjYwNDg5MDE0ZGExNGQzNzhmODAyY2Q0ODc2N2MwMjgvdGFibGU6OWQ1ODIzMmNhMTFiNDk2ZTliZWQ2MTkxNDhjOWJhNDYvdGFibGVyYW5nZTo5ZDU4MjMyY2ExMWI0OTZlOWJlZDYxOTE0OGM5YmE0Nl8wLTEtMS0xLTA_2d9b2b2c-0f2e-494f-b3d7-fc601691a99c">0001062822</ix:nonNumeric><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY180L2ZyYWc6ZjYwNDg5MDE0ZGExNGQzNzhmODAyY2Q0ODc2N2MwMjgvdGFibGU6OWQ1ODIzMmNhMTFiNDk2ZTliZWQ2MTkxNDhjOWJhNDYvdGFibGVyYW5nZTo5ZDU4MjMyY2ExMWI0OTZlOWJlZDYxOTE0OGM5YmE0Nl8xLTEtMS0xLTA_8c3408e8-6000-49bc-baa0-9b430deb1815">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lxrx-20200729.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001062822</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-29</xbrli:startDate><xbrli:endDate>2020-07-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i23ecade57804410bb798455d50d75cec_1"></div><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">UNITED STATES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Washington, D.C. 20549</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">__________________</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%;">FORM <ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg0_c7dd568c-d362-4db6-bee0-f25b5c84c5e7">8-K</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">__________________</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;">CURRENT REPORT</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8yNjY_9a67cebd-d5c3-4210-978a-82660ed50058">July 29, 2020</ix:nonNumeric></span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg5_d968fa89-3287-4012-983a-6e529e823639">Lexicon Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.274%;"><tr><td style="width:1.0%;"></td><td style="width:31.855%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:29.191%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:32.954%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:12pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmZjODZjMDZjZjQ2NDkwMGIyMTgxZGJjNzUwOGZkZjYvdGFibGVyYW5nZTpiZmM4NmMwNmNmNDY0OTAwYjIxODFkYmM3NTA4ZmRmNl8wLTAtMS0xLTA_827fab9e-7ccc-4908-a5f8-04baa95866ee">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:12pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmZjODZjMDZjZjQ2NDkwMGIyMTgxZGJjNzUwOGZkZjYvdGFibGVyYW5nZTpiZmM4NmMwNmNmNDY0OTAwYjIxODFkYmM3NTA4ZmRmNl8wLTEtMS0xLTA_eeb721fc-7c98-448d-b33a-3025e77f8caf">000-30111</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:12pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmZjODZjMDZjZjQ2NDkwMGIyMTgxZGJjNzUwOGZkZjYvdGFibGVyYW5nZTpiZmM4NmMwNmNmNDY0OTAwYjIxODFkYmM3NTA4ZmRmNl8wLTItMS0xLTA_c0a07129-5248-4343-b9e2-a11bb106ddd7">76-0474169</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Commission File Number)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjgw_74a6bb18-e74a-420c-ad37-1b4093b97c33">8800 Technology Forest Place</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjk0_af344794-5df0-4582-b3f4-edad5f53ab55">The Woodlands</ix:nonNumeric>, <ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjky_02ebe7a5-6fc9-4828-b0b7-df578d0449fe">Texas</ix:nonNumeric> <ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl80MDk_784cced8-eaf7-488f-9e31-45469151630d">77381</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(Address of principal executive offices and Zip Code)</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">(<ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl80Njg_84a198f5-0379-4387-82e8-b3130ea84051">281</ix:nonNumeric>) <ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg1_ad0fb78d-cf89-4f00-b0e5-6791fd14c544">863-3000</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-indent:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.421%;"><tr><td style="width:1.0%;"></td><td style="width:33.524%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:21.004%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:39.472%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol(s)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmMxMzA4NTczNTY0NDRkNjk3Nzg3ZjYyMzVhM2NmOTAvdGFibGVyYW5nZTpiYzEzMDg1NzM1NjQ0NGQ2OTc3ODdmNjIzNWEzY2Y5MF8xLTAtMS0xLTA_efdf536d-7bb5-4a1f-a218-123c67bf3778">Common Stock, par value $0.001</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmMxMzA4NTczNTY0NDRkNjk3Nzg3ZjYyMzVhM2NmOTAvdGFibGVyYW5nZTpiYzEzMDg1NzM1NjQ0NGQ2OTc3ODdmNjIzNWEzY2Y5MF8xLTEtMS0xLTA_7e5b2964-5625-41ab-8211-7a2ae048cbd6">LXRX</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmMxMzA4NTczNTY0NDRkNjk3Nzg3ZjYyMzVhM2NmOTAvdGFibGVyYW5nZTpiYzEzMDg1NzM1NjQ0NGQ2OTc3ODdmNjIzNWEzY2Y5MF8xLTItMS0xLTA_ba976686-ba26-4aad-911a-5a4f1fb4345e">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:18pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</span></div><div style="text-indent:-36pt;padding-left:72pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg2_ad083629-27b2-4848-887b-5b8cd230af6c">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Written communications pursuant to Rule 425 under the Securities Act (17&#160;CFR&#160;230.425)</span></div><div style="text-indent:-36pt;padding-left:72pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjkx_98c8e77a-d151-4b5e-bc5c-aa7180348dc3">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17&#160;CFR 240.14a-12)</span></div><div style="text-indent:-36pt;padding-left:72pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjkw_b2f9cbd9-0cad-4d3e-8a99-7d776cd74b2b">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR 240.14d-2(b))</span></div><div style="text-indent:-36pt;padding-left:72pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg4_03bd60c1-53e3-4e5a-97d4-34da287c2359">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></div><div style="text-indent:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div><div style="padding-left:36pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Emerging growth company  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjkz_e66d1e78-71a1-4f7a-bb6b-2bdf3116856f">&#9744;</ix:nonNumeric></span></div><div style="text-indent:36pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">&#9744;</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-indent:36pt;margin-bottom:6pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="i23ecade57804410bb798455d50d75cec_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%;">Item 1.01&#160;Entry into a Material Definitive Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">On July 29, 2020, Lexicon Pharmaceuticals, Inc. (the &#8220;Company&#8221;) and TerSera Therapeutics LLC (&#8220;TerSera&#8221;) entered into an Asset Purchase and Sale Agreement (the &#8220;Purchase and Sale Agreement&#8221;) pursuant to which the Company agreed to sell to TerSera the Company&#8217;s XERMELO&#174; (telotristat ethyl) product and related assets.</span></div><div><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">The consideration to be paid by TerSera pursuant to the Purchase and Sale Agreement will consist of: (a) an upfront cash payment payable at the closing of the transaction expected to be equal to approximately $159,000,000, including the book value of inventory, subject to working capital and other adjustments set forth in the Purchase and Sale Agreement, and (b) the following potential future contingent payments: (i) development, regulatory and sales milestone payments of up to an aggregate of $65 million for the development and commercialization of XERMELO in patients with biliary tract cancer and (ii) mid-teens percentage royalty payments on net sales of XERMELO in biliary tract cancer.</span></div><div><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">In connection with the closing of the transaction, the Company expects to repay (or cause to be repaid) in full the Company&#8217;s borrowings under its Loan Agreement, dated December 4, 2017, with BioPharma Credit PLC, as collateral agent and a lender, and BioPharma Credit Investments IV Sub LP, as a lender.</span></div><div style="text-indent:36pt;"><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">The transaction is expected to close in the third quarter of 2020, subject to the satisfaction or waiver of customary conditions, including the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</span></div><div><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">The Purchase and Sale Agreement contains representations, warranties and covenants as to the parties&#8217; business, financial and legal obligations and provides for indemnification by each of the parties in certain circumstances.</span></div><div><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">The Purchase and Sale Agreement and this summary are not intended to modify or supplement any factual disclosures about the Company or TerSera. The foregoing descriptions of the transaction and the Purchase and Sale Agreement do not purport to be complete and are qualified in their entirety by reference to the complete text of the Purchase and Sale Agreement, which the Company intends to file with a future filing with the Securities and Exchange Commission.</span></div><div><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">The representations, warranties and covenants contained in the Purchase and Sale Agreement were made only for the purposes of the Purchase and Sale Agreement, were made as of specific dates, were made solely for the benefit of the parties to the Purchase and Sale Agreement and may not have been intended to be statements of fact but, rather, as a method of allocating risk and governing the contractual rights and relationships between the parties to the Purchase and Sale Agreement. The assertions embodied in those representations and warranties may be subject to important qualifications and limitations agreed to by the Company and TerSera in connection with negotiating their respective terms. Moreover, the representations and warranties may be subject to a contractual standard of materiality that may be different from what may be viewed as material to stockholders. For the foregoing reasons, none of the Company&#8217;s stockholders or any other person should rely on such representations and warranties, or any characterizations thereof, as statements of factual information at the time they were made or otherwise.</span></div><div><span><br/></span></div><div style="text-indent:36pt;"><span><br/></span></div><div id="i23ecade57804410bb798455d50d75cec_121"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%;">Item 8&#160;.01&#160;Other Events</span></div><div><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">On July 30, 2020, the Company issued a press release announcing the execution of the Purchase and Sale Agreement with TerSera. The full text of the press release issued in connection with the announcement is attached hereto as Exhibit 99.1 and incorporated herein by this reference.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Safe Harbor</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Statements contained in this Current Report on Form 8-K about the Company, the Purchase and Sale Agreement and the transaction that are not purely historical, and all other statements that are not purely historical, may be deemed to be forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Without limiting the foregoing, the words &#8220;believes,&#8221; &#8220;anticipates&#8221; and &#8220;expects&#8221; and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties that may cause the Company&#8217;s actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements.  Important factors that may cause or contribute to such differences include the parties&#8217; ability to consummate the transaction; the conditions to the completion of the transaction, including without limitation the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to the transaction; the parties&#8217; ability to meet expectations regarding the timing, completion and accounting and tax treatments of the transaction; the anticipated cash and non-cash charges associated with the transaction; the ability of the Company to successfully separate the XERMELO&#174; business from the Company&#8217;s other businesses; the commercial success of telotristat ethyl for the treatment of BTC and the risk that future milestone and royalty payments may not be received by the Company on the terms negotiated with TerSera or at all; and such other factors as are set forth in the risk factors detailed from time to time in the Company&#8217;s filings with the Securities and Exchange Commission, including, without limitation, the risk factors detailed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019 and the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, which are incorporated herein by reference. The Company specifically disclaims any obligation to update these forward-looking statements, unless required by law.</span></div><div><span><br/></span></div><div id="i23ecade57804410bb798455d50d75cec_10"></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%;">Item 9.01&#160;Financial Statements and Exhibits </span></div><div><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(d)&#160;Exhibits </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.935%;"><tr><td style="width:1.0%;"></td><td style="width:11.987%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.717%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:76.296%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Exhibit No.</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Description</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="pressrelease07-30x020.htm">Press Release Issued by the Company on July 30, 2020</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="i23ecade57804410bb798455d50d75cec_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Signatures</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:36pt;text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.982%;"><tr><td style="width:1.0%;"></td><td style="width:51.930%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.547%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:36.523%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:11pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Lexicon Pharmaceuticals, Inc.</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date:   July 30, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Brian T. Crum</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Brian T. Crum</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;">Vice</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;">President and General Counsel</span></div></td></tr></table></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="i23ecade57804410bb798455d50d75cec_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Index to Exhibits</span></div><div style="text-align:justify;"><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.421%;"><tr><td style="width:1.0%;"></td><td style="width:11.302%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.607%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:76.091%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Exhibit No.</span></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Description</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="pressrelease07-30x020.htm">Press Release Issued by the Company on July 30, 2020</a></span></div></td></tr></table></div><div style="text-indent:-36pt;padding-left:36pt;text-align:justify;"><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressrelease07-30x020.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i753ac549b0c641af8a5d0eefedd0a8cd_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Exhibit 99.1</font></div><div style="text-align:center;"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%;">LEXICON PHARMACEUTICALS ENTERS INTO AGREEMENT</font></div><div style="text-align:center;"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">WITH TERSERA THERAPEUTICS FOR THE SALE OF XERMELO</font></div><div><font><br></font></div><div style="text-align:center;"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Lexicon to Receive Up to $224 Million in Upfront and Milestone Payments Plus Mid-Teens Royalties on Net Sales of XERMELO in Biliary Tract Cancer</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">The Woodlands, Texas and Deerfield, Illinois,</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">  July 30, 2020 &#8211; Lexicon Pharmaceuticals, Inc. (Nasdaq&#58; LXRX) and TerSera Therapeutics LLC announced today that they have entered into an asset purchase and sale agreement for the sale to TerSera of Lexicon&#8217;s rights, title and interest in XERMELO&#174; (telotristat ethyl).  </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Pursuant to the terms of the agreement, TerSera will pay Lexicon approximately $159 million in cash at closing, which includes a $155 million upfront payment and approximately $4 million for existing inventory.  Lexicon may receive additional development, regulatory and sales milestone payments of up to an aggregate of $65 million for the development and commercialization of telotristat ethyl in patients with biliary tract cancer.  Additionally, Lexicon will be eligible to receive mid-teens royalties on net sales of XERMELO in biliary tract cancer.  As part of the transaction, TerSera has agreed to assume the currently ongoing TELE-ABC Phase 2 clinical study of XERMELO in biliary tract cancer patients and offer employment to at least 20 Lexicon employees currently dedicated to XERMELO.  The transaction is expected to close in the third quarter of 2020, subject to customary closing conditions.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8220;This agreement allows us to focus Lexicon around LX9211 for neuropathic pain and other early-stage research and development programs, enabling efficient use of our resources and substantially reducing our debt,&#8221; said Lonnel Coats, Lexicon&#8217;s president and chief executive officer. &#8220;TerSera&#8217;s dedicated oncology focus will provide physicians and patients continued access to this important medicine for carcinoid syndrome diarrhea and continue its ongoing development for people suffering with biliary tract cancer.&#8221;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8220;XERMELO continues to gain an increasingly important role in carcinoid syndrome diarrhea with a potential future role in other cancers,&#8221; said Ed Fiorentino, Chairman &#38; CEO of TerSera. &#8220;We are very excited to add XERMELO to our existing oncology portfolio.&#8221; </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">About XERMELO (telotristat ethyl)</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Discovered using Lexicon&#8217;s unique approach to gene science, XERMELO is the first and only approved oral therapy for carcinoid syndrome diarrhea. XERMELO targets tryptophan hydroxylase, an enzyme that mediates the excess serotonin production within metastatic neuroendocrine tumor (mNET) cells. XERMELO is approved in the United States, the European Union and certain additional countries for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. Carcinoid syndrome is a rare condition that occurs in patients living with mNETs and is characterized by frequent and debilitating diarrhea. XERMELO targets the overproduction of serotonin inside mNET cells, providing an additional treatment option for patients suffering from carcinoid syndrome diarrhea.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Lexicon has granted Ipsen an exclusive royalty-bearing right and license to commercialize XERMELO outside of the United States and Japan. Lexicon is commercializing XERMELO in the United States and Ipsen is commercializing XERMELO in multiple countries, including the United Kingdom and Germany.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">XERMELO (telotristat ethyl) Important Safety Information </font></div><div><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.15pt;">Warnings and Precautions</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#58; XERMELO may cause constipation, which can be serious. Monitor for signs and symptoms of constipation and&#47;or severe, persistent, or worsening abdominal pain in patients taking </font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="padding-left:36pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">XERMELO. Discontinue XERMELO if severe constipation or severe, persistent, or worsening abdominal pain develops. </font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.15pt;">Adverse Reactions&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> The most common adverse reactions (&#8805;5%) include nausea, headache, increased gamma-glutamyl-transferase, depression, flatulence, decreased appetite, peripheral edema, and pyrexia.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.15pt;">Drug Interactions&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> If necessary, consider increasing the dose of concomitant CYP3A4 substrates, as XERMELO may decrease their systemic exposure. If combination treatment with XERMELO and short-acting octreotide is needed, administer short-acting octreotide at least 30 minutes after administering XERMELO. </font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">For more information about XERMELO, see Full Prescribing Information at www.xermelo.com.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">About Lexicon Pharmaceuticals</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Lexicon is a fully integrated biopharmaceutical company with a mission of pioneering medicines that transform patients&#8217; lives. Through its Genome5000&#8482; program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. In addition to its first commercial product, XERMELO, Lexicon has a pipeline of promising drug candidates in clinical and preclinical development in diabetes and metabolism, oncology and neuropathic pain. For additional information, please visit www.lexpharma.com.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">About TerSera Therapeutics </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">TerSera Therapeutics acquires, develops and markets specialty pharmaceutical products with a focus on oncology and non-opioid pain.  Its mission is to provide products which truly make a difference for patients.  For more information about TerSera Therapeutics, please visit www.tersera.com.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Safe Harbor Statement</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;">This press release contains &#8220;forward-looking statements,&#8221; including statements relating to the sale of XERMELO (telotristat ethyl) and Lexicon&#8217;s long-term outlook on its business. In addition, this press release also contains forward looking statements relating to Lexicon&#8217;s growth and future operating results, discovery, development and commercialization of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management&#8217;s current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including Lexicon&#8217;s ability to meet its capital requirements, successfully complete the sale of XERMELO, successfully conduct preclinical and clinical development and obtain necessary regulatory approvals of sotagliflozin, LX9211 and its other potential drug candidates on its anticipated timelines, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates. Any of these risks, uncertainties and other factors may cause Lexicon&#8217;s actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under &#8220;Risk Factors&#8221; in Lexicon&#8217;s annual report on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;"><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><div id="i753ac549b0c641af8a5d0eefedd0a8cd_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%;">For Investor Inquiries</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;">&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;">Kimberly Lee, D.O.</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;">Head of Investor Relations and Corporate Strategy</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;">Lexicon Pharmaceuticals</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;">(281) 863-3383</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;text-decoration: underline;">klee&#64;lexpharma.com</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%;">For Media Inquiries&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;">Chas Schultz</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;">Senior Director, Corporate Communications and Advocacy</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;">Lexicon Pharmaceuticals</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;">(281) 863-3421</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:144%;text-decoration: underline;">cschultz&#64;lexpharma.com</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">TerSera Therapeutics LLC Contact&#58;</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Mark Leonard </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">+1 847 651 9682 or mark&#64;reachthenextlevel.com</font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lxrx-20200729.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:0f0ad0d9-de60-4423-9f15-cf8fc17a97ed,g:f4dc18c7-48ee-4acb-af6f-6184735fdbf4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lxrx="http://www.lexpharma.com/20200729" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lexpharma.com/20200729">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20200729_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20200729_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20200729_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lxrx-20200729_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.lexpharma.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>lxrx-20200729_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:0f0ad0d9-de60-4423-9f15-cf8fc17a97ed,g:f4dc18c7-48ee-4acb-af6f-6184735fdbf4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lexpharma.com/role/Cover" xlink:type="simple" xlink:href="lxrx-20200729.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.lexpharma.com/role/Cover" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>lxrx-20200729_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:0f0ad0d9-de60-4423-9f15-cf8fc17a97ed,g:f4dc18c7-48ee-4acb-af6f-6184735fdbf4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.lexpharma.com/role/Cover" xlink:type="simple" xlink:href="lxrx-20200729.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.lexpharma.com/role/Cover" xlink:type="extended" id="i015b13d3d40c4aaf81272bc876dec2ed_Cover"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>lxrx-20200729_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:0f0ad0d9-de60-4423-9f15-cf8fc17a97ed,g:f4dc18c7-48ee-4acb-af6f-6184735fdbf4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_7ad5e254-346e-4cf8-8974-d6930e7f11dd_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_0fdff6fd-a01a-4b51-bce4-b486c5a1f1bd_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_46ee5e18-5c8b-4674-896d-889b874dcb4a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3fb11f88-29c4-4fc9-ac28-17b2237fddcd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ba027d47-c386-4664-ba9e-1e1c3f79130a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a25c16f2-c0e3-46b0-97f6-11a11ae3c73d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_fd2fade8-2e19-4305-811a-0429951d72f6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8eecd2ed-4660-47b3-a0e1-7186b49306d6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c022b127-b89b-44fb-a887-d561f16376c4_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ab83b7cf-4d1b-41ea-b643-3592953f14fb_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c9b8f0ec-736d-4b2d-bc6c-b4085ed4ff4b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6f650867-5cc8-4bda-9ae1-2312485b3f33_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8a7bae24-861f-49d0-be90-1485ba0ed187_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_eb03e790-e7e1-4c75-9cb7-c1600572e769_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_21d3d2ef-38df-4d21-89f5-198bbd7ba506_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_14347f5f-cefc-4029-a6a6-0cd012bdc3df_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_64b57cc6-1c49-4c23-afe1-f67a3dee22b5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4de1c74e-1462-4f6d-a2a5-c819cc6ccfe1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_977e4037-64dd-494f-956a-e286e0122fe7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cc3f63b9-1952-4f1b-ad1e-aed38acc8eb4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_329e98e3-3eb4-4fcb-94dd-73cac6e8a202_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1ad13cc9-7a14-4e30-84ee-33ac53c889c0_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>lxrx-20200729_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:0f0ad0d9-de60-4423-9f15-cf8fc17a97ed,g:f4dc18c7-48ee-4acb-af6f-6184735fdbf4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lexpharma.com/role/Cover" xlink:type="simple" xlink:href="lxrx-20200729.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.lexpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a9631a41-1792-43dd-b49a-b4016f76a6f5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_DocumentType_a9631a41-1792-43dd-b49a-b4016f76a6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4947e24c-291d-490a-88d2-5dc4641337ef" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_DocumentPeriodEndDate_4947e24c-291d-490a-88d2-5dc4641337ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cc3aefc5-41dc-4354-9631-3b2643dc9720" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityRegistrantName_cc3aefc5-41dc-4354-9631-3b2643dc9720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bf518bdc-05d2-4531-9e50-d001682e6677" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bf518bdc-05d2-4531-9e50-d001682e6677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9e24e7a1-13c8-4638-b81f-c9d26326124d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityFileNumber_9e24e7a1-13c8-4638-b81f-c9d26326124d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_794fe9fe-01f3-432e-85cf-0a65d26048ed" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityTaxIdentificationNumber_794fe9fe-01f3-432e-85cf-0a65d26048ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e67e26d7-2cd8-4b39-b47d-e1b17345c243" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityAddressAddressLine1_e67e26d7-2cd8-4b39-b47d-e1b17345c243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3f5663e0-e257-499c-a3b4-dc61f7f69375" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityAddressCityOrTown_3f5663e0-e257-499c-a3b4-dc61f7f69375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7c673813-69df-4b20-9957-40453f010eff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityAddressStateOrProvince_7c673813-69df-4b20-9957-40453f010eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f9359551-4ef4-4142-9e91-7df2e9bb0ca1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityAddressPostalZipCode_f9359551-4ef4-4142-9e91-7df2e9bb0ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_03bf447a-4314-4443-98af-63e8292561fb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_CityAreaCode_03bf447a-4314-4443-98af-63e8292561fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_68814635-88cd-4bad-bc79-47861c13cd44" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_LocalPhoneNumber_68814635-88cd-4bad-bc79-47861c13cd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1196c70c-7083-45e8-8f61-82be77268527" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_Security12bTitle_1196c70c-7083-45e8-8f61-82be77268527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_13331ed8-cbc0-4da9-962f-144056bfbd2f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_TradingSymbol_13331ed8-cbc0-4da9-962f-144056bfbd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6644d4d6-a5b2-49a5-aa10-c4f78ae73253" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_SecurityExchangeName_6644d4d6-a5b2-49a5-aa10-c4f78ae73253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_2b80e906-b9fc-427a-9e29-c79d16419fe1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_WrittenCommunications_2b80e906-b9fc-427a-9e29-c79d16419fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b6113fc8-96c0-43a0-9f64-afcc207f1541" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_SolicitingMaterial_b6113fc8-96c0-43a0-9f64-afcc207f1541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_c1755a52-2570-427f-ad43-ad78c8809d80" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_PreCommencementTenderOffer_c1755a52-2570-427f-ad43-ad78c8809d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_54c7f22a-c2be-41cf-a778-0fd216a8ffc8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_54c7f22a-c2be-41cf-a778-0fd216a8ffc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_444f0762-6db2-458a-b1d5-fa4730e21c91" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityEmergingGrowthCompany_444f0762-6db2-458a-b1d5-fa4730e21c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_de5b9a69-6e43-4019-ad0c-2a2d74b02428" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_EntityCentralIndexKey_de5b9a69-6e43-4019-ad0c-2a2d74b02428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_fc416802-88ab-445b-a57d-4720474f0fd0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_198ce92b-c9e6-4721-b791-bb7cbecdd18d" xlink:to="loc_dei_AmendmentFlag_fc416802-88ab-445b-a57d-4720474f0fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>lxrx-20200729_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lxrx-20200729.xsd" xlink:type="simple"/>
    <context id="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001062822</identifier>
        </entity>
        <period>
            <startDate>2020-07-29</startDate>
            <endDate>2020-07-29</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY180L2ZyYWc6ZjYwNDg5MDE0ZGExNGQzNzhmODAyY2Q0ODc2N2MwMjgvdGFibGU6OWQ1ODIzMmNhMTFiNDk2ZTliZWQ2MTkxNDhjOWJhNDYvdGFibGVyYW5nZTo5ZDU4MjMyY2ExMWI0OTZlOWJlZDYxOTE0OGM5YmE0Nl8wLTEtMS0xLTA_2d9b2b2c-0f2e-494f-b3d7-fc601691a99c">0001062822</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY180L2ZyYWc6ZjYwNDg5MDE0ZGExNGQzNzhmODAyY2Q0ODc2N2MwMjgvdGFibGU6OWQ1ODIzMmNhMTFiNDk2ZTliZWQ2MTkxNDhjOWJhNDYvdGFibGVyYW5nZTo5ZDU4MjMyY2ExMWI0OTZlOWJlZDYxOTE0OGM5YmE0Nl8xLTEtMS0xLTA_8c3408e8-6000-49bc-baa0-9b430deb1815">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg0_c7dd568c-d362-4db6-bee0-f25b5c84c5e7">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8yNjY_9a67cebd-d5c3-4210-978a-82660ed50058">2020-07-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg5_d968fa89-3287-4012-983a-6e529e823639">Lexicon Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmZjODZjMDZjZjQ2NDkwMGIyMTgxZGJjNzUwOGZkZjYvdGFibGVyYW5nZTpiZmM4NmMwNmNmNDY0OTAwYjIxODFkYmM3NTA4ZmRmNl8wLTAtMS0xLTA_827fab9e-7ccc-4908-a5f8-04baa95866ee">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmZjODZjMDZjZjQ2NDkwMGIyMTgxZGJjNzUwOGZkZjYvdGFibGVyYW5nZTpiZmM4NmMwNmNmNDY0OTAwYjIxODFkYmM3NTA4ZmRmNl8wLTEtMS0xLTA_eeb721fc-7c98-448d-b33a-3025e77f8caf">000-30111</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmZjODZjMDZjZjQ2NDkwMGIyMTgxZGJjNzUwOGZkZjYvdGFibGVyYW5nZTpiZmM4NmMwNmNmNDY0OTAwYjIxODFkYmM3NTA4ZmRmNl8wLTItMS0xLTA_c0a07129-5248-4343-b9e2-a11bb106ddd7">76-0474169</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjgw_74a6bb18-e74a-420c-ad37-1b4093b97c33">8800 Technology Forest Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjk0_af344794-5df0-4582-b3f4-edad5f53ab55">The Woodlands</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjky_02ebe7a5-6fc9-4828-b0b7-df578d0449fe">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl80MDk_784cced8-eaf7-488f-9e31-45469151630d">77381</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl80Njg_84a198f5-0379-4387-82e8-b3130ea84051">281</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg1_ad0fb78d-cf89-4f00-b0e5-6791fd14c544">863-3000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmMxMzA4NTczNTY0NDRkNjk3Nzg3ZjYyMzVhM2NmOTAvdGFibGVyYW5nZTpiYzEzMDg1NzM1NjQ0NGQ2OTc3ODdmNjIzNWEzY2Y5MF8xLTAtMS0xLTA_efdf536d-7bb5-4a1f-a218-123c67bf3778">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmMxMzA4NTczNTY0NDRkNjk3Nzg3ZjYyMzVhM2NmOTAvdGFibGVyYW5nZTpiYzEzMDg1NzM1NjQ0NGQ2OTc3ODdmNjIzNWEzY2Y5MF8xLTEtMS0xLTA_7e5b2964-5625-41ab-8211-7a2ae048cbd6">LXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGFibGU6YmMxMzA4NTczNTY0NDRkNjk3Nzg3ZjYyMzVhM2NmOTAvdGFibGVyYW5nZTpiYzEzMDg1NzM1NjQ0NGQ2OTc3ODdmNjIzNWEzY2Y5MF8xLTItMS0xLTA_ba976686-ba26-4aad-911a-5a4f1fb4345e">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg2_ad083629-27b2-4848-887b-5b8cd230af6c">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjkx_98c8e77a-d151-4b5e-bc5c-aa7180348dc3">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjkw_b2f9cbd9-0cad-4d3e-8a99-7d776cd74b2b">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjg4_03bd60c1-53e3-4e5a-97d4-34da287c2359">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjIzZWNhZGU1NzgwNDQxMGJiNzk4NDU1ZDUwZDc1Y2VjL3NlYzoyM2VjYWRlNTc4MDQ0MTBiYjc5ODQ1NWQ1MGQ3NWNlY18xL2ZyYWc6ODZjMDA1ODVlMTVhNGIzODk1YzI5YzlmNGZhM2M3NzYvdGV4dHJlZ2lvbjo4NmMwMDU4NWUxNWE0YjM4OTVjMjljOWY0ZmEzYzc3Nl8xNjkz_e66d1e78-71a1-4f7a-bb6b-2bdf3116856f">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140120479715112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 29, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 29,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Lexicon Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0474169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8800 Technology Forest Place<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">The Woodlands<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">863-3000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LXRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001062822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
M1CK^4 =!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " !&.OY0_:>:;>X    K @  $0
M@ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !&.OY0F5R<(Q &
M  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( $8Z_E"V^Q33-@0  #T0   8              " @0T(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !&.OY0@ZFE ]0!
M   R!@  #0              @ %Y#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( $8Z_E"7BKL<P    !,"   +              "  7@.  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( $8Z_E"JQ"(6,P$  "("   /              "
M 6$/  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !&.OY0)!Z;HJT   #X
M 0  &@              @ '!$   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " !&.OY099!YDAD!  #/ P  $P              @ &F
L$0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #P$@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lxrx-20200729.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lexpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="lxrx-20200729.htm">lxrx-20200729.htm</File>
    <File>lxrx-20200729.xsd</File>
    <File>lxrx-20200729_cal.xml</File>
    <File>lxrx-20200729_def.xml</File>
    <File>lxrx-20200729_lab.xml</File>
    <File>lxrx-20200729_pre.xml</File>
    <File>pressrelease07-30x020.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lxrx-20200729.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "lxrx-20200729_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lxrx-20200729_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lxrx-20200729.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lxrx-20200729_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lxrx-20200729_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lxrx-20200729.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lxrx",
   "nsuri": "http://www.lexpharma.com/20200729",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20200729.htm",
      "contextRef": "iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.lexpharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lxrx-20200729.htm",
      "contextRef": "iedd03d7bcfc34c3da6ff571d702f8ae5_D20200729-20200729",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.lexpharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001062822-20-000045-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001062822-20-000045-xbrl.zip
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MBNH#AC>9P16'NJYB,]NN^<PV/=W[#106F*[X,UQ_<)G53*;(3<'5U3>O\*;
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M!H)1(<^=['02+EV%'[B!<E887\J5SW?8PZ.(S%U4N$'NO0Z.O$.#C\GG.KA
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M[?88WW"$!BT89(-$\@%174$5V1'03KP'[_L:1+>?-P9X<P"""N.6[:;05TI
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M6D?-!.N*$)^BPU%@FAZXJK F0@'<X4#+"2((7NR5[*,#5$VB<J%%RB:%@LO
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M[_@Y-&(&J+]2#P$#X42C!(>14S@\"?,2J7[ .W8_/Y%2V4:ECK2QHA"2JVW
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MR'_T +.#08#P AORYIVWJQ]02P,$%     @ 1CK^4&EVI/8' @  ;08  !4
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M_QO>)&B0E7ZC9WCB[OK.R@N<@&T+58#;G=V;*&O_8%'9Z5I_O;*T#LK^[#)
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M,C R,# W,CDN:'1M4$L! A0#%     @ 1CK^4&;BHC:( @  >@D  !$
M         ( !5QP  &QX<G@M,C R,# W,CDN>'-D4$L! A0#%     @ 1CK^
M4!9&)1&" 0  R (  !4              ( !#A\  &QX<G@M,C R,# W,CE?
M8V%L+GAM;%!+ 0(4 Q0    ( $8Z_E!I=J3V!P(  &T&   5
M  "  <,@  !L>')X+3(P,C P-S(Y7V1E9BYX;6Q02P$"% ,4    " !&.OY0
M%BT@H%H*  "B70  %0              @ '](@  ;'AR>"TR,#(P,#<R.5]L
M86(N>&UL4$L! A0#%     @ 1CK^4. >(/FL!@  :#$  !4
M ( !BBT  &QX<G@M,C R,# W,CE?<')E+GAM;%!+ 0(4 Q0    ( $8Z_E H
MYCQ>;Q   "%(   9              "  6DT  !P<F5S<W)E;&5A<V4P-RTS
?,'@P,C N:'1M4$L%!@     '  < T0$   ]%      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
